Alan - Advanced Biomed Director Relations
| ADVB Stock | 0.24 0 0.58% |
Director
Alan is Director Relations of Advanced Biomed Common
| Address | 122 East 42nd Street, New York, NY, United States, 10168 |
| Web | https://www.advanbiomed.com |
Advanced Biomed Management Efficiency
The company has return on total asset (ROA) of (0.269) % which means that it has lost $0.269 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.8018 %, meaning that it created $0.8018 on every $100 dollars invested by stockholders. Advanced Biomed's management efficiency ratios could be used to measure how well Advanced Biomed manages its routine affairs as well as how well it operates its assets and liabilities. As of February 17, 2026, Return On Tangible Assets is expected to decline to -0. In addition to that, Return On Capital Employed is expected to decline to -0. At present, Advanced Biomed's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 579.3 M, whereas Return On Tangible Assets are forecasted to decline to (0.000015).Similar Executives
| Found 7 records | DIRECTOR Age | ||
| James Walsh | Trinity Biotech plc | 68 | |
| Jacqueline ONeill | Trinity Biotech plc | 53 | |
| MariaBernadette Madel | Marker Therapeutics | 36 | |
| Elizabeth Donnelly | Marker Therapeutics | N/A | |
| Robert Goodman | Beyond Air | 61 | |
| Ronan ACA | Trinity Biotech plc | 70 | |
| Steve Liu | Ridgetech | N/A | |
Management Performance
| Return On Equity | 0.8 | ||||
| Return On Asset | -0.27 |
Advanced Biomed Common Leadership Team
Elected by the shareholders, the Advanced Biomed's board of directors comprises two types of representatives: Advanced Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Advanced. The board's role is to monitor Advanced Biomed's management team and ensure that shareholders' interests are well served. Advanced Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Advanced Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mingze Yin, Chief Officer | ||
| Hung Pau, Secretary Director | ||
| Alan, Director Relations | ||
| Yi Lu, CEO Chairman | ||
| IFang Cheng, Chief Officer |
Advanced Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Advanced Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.8 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 4.06 M | ||||
| Shares Outstanding | 27.29 M | ||||
| Shares Owned By Insiders | 77.20 % | ||||
| Shares Owned By Institutions | 0.97 % | ||||
| Number Of Shares Shorted | 88.63 K | ||||
| Price To Book | 2.23 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advanced Biomed Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Advanced Biomed assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Advanced Biomed Common requires distinguishing between market price and book value, where the latter reflects Advanced's accounting equity. The concept of intrinsic value - what Advanced Biomed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Advanced Biomed's price substantially above or below its fundamental value.
Understanding that Advanced Biomed's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Advanced Biomed represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Advanced Biomed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.